Seeking Alpha

CVS Caremark (CVS -4.4%) weighs in on the impact of the new Walgreen-Express Scripts agreement....

CVS Caremark (CVS -4.4%) weighs in on the impact of the new Walgreen-Express Scripts agreement. The drugstore operator adds $0.05 to its overall FY12 estimate of extra business from the WAG-ESRX dispute after factoring in that it will retain 50% of the customers it gained from Walgreen through Q4.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector